NCT02147379View on ClinicalTrials.gov

Lurasidone and Cognition in Bipolar I Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

January 12, 2017

Conditions
Bipolar I Disorder
Interventions
DRUG

Lurasidone

Trial Locations (1)

V6T 2A1

University of British Columbia, Department of Psychiatry, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT02147379 - Lurasidone and Cognition in Bipolar I Disorder | Biotech Hunter | Biotech Hunter